CR1L Antikörper (AA 274-323)
Kurzübersicht für CR1L Antikörper (AA 274-323) (ABIN6749551)
Target
Alle CR1L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 274-323
-
Spezifität
- Human CR1L
-
Homologie
- Percent identity by BLAST analysis:
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa274-323 of human CR1L (Q2VPA4, NP_783641). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon (100%), Baboon, Monkey, Marmoset (84%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CR1L (Complement Component (3b/4b) Receptor 1-Like (CR1L))
-
Andere Bezeichnung
- CR1L / CRRY
-
Hintergrund
-
Name/Gene ID: CR1L
Synonyms: CR1L, Cr1l, Crry -
Gen-ID
- 1379
-
NCBI Accession
- NP_783641
-
UniProt
- Q2VPA4
-
Pathways
- Komplementsystem
Target
-